Infagen Remedies LLP
About Infagen Remedies LLP
Data last updated:
Infagen Remedies LLP is a limited liability partnership (LLP) based in Sonipat, Haryana, India. It operates in the commission-based trading segment of the business services sector. It was incorporated on 31 May 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAS-5126. The LLP has 1 GST registration on record, which is no longer active.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Harish Kumar Kinger and Raj Kumar.
Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at 477 Sector 15, Sonipat, Haryana, India – 131001.
Court records list 1 case involving the LLP, including 1 filed by the LLP; 1 case is pending.
Company details
Contact details
Infagen Remedies LLP's registered office is in Sonipat, Haryana.
- Registered Address477 Sector 15, Sonipat, Haryana, India – 131001
- IndustryBusiness Services, Commission Trade, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Infagen Remedies LLP
FY 2023 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | |||
| Other Income | |||
| Total Income | |||
| Purchases and Direct Costs | |||
| Personnel Expenses | |||
| Administrative Expenses | |||
| Interest | |||
| Depreciation | |||
| Total Expenses | |||
| Profit Before Tax | |||
| Tax | |||
| Profit After Tax | |||
| Profit Transferred to Partners | |||
| Assets and Liabilities | |||
| Partners' Contribution | |||
| Reserves and Surplus | |||
| Secured Loans | |||
| Unsecured Loans | |||
| Trade Payables | |||
| Other Liabilities and Provisions | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Loans and Advances | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | |||
| Return on Partners' Funds | |||
| Return on Assets | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Debt to Partners' Funds | |||
| Interest Coverage | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Turnover Growth | |||
| Profit Growth | |||
To see the full financial statements and ratios of Infagen Remedies LLP, buy the company report.
Designated partners of Infagen Remedies LLP
Infagen Remedies has 3 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harish Kumar Kinger | Designated Partner | 31 May 2020 | 6 Years 4 Months | Current |
| Raj Kumar Also directs: Infar Lifesciences Private Limited | Designated Partner | 31 May 2020 | 6 Years 4 Months | Current |
| Rajesh Kumar Also directs: Infagen Pharma LLP, Infar Lifesciences Private Limited | Designated Partner | 31 May 2020 | 6 Years 4 Months | Current |
Legal cases
Infagen Remedies LLP has 1 court case on record: 1 filed by Infagen Remedies. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sonepat, Haryana | Cheque dishonour complaint | Filed by the company against individuals | Pending |
To see the full case history of Infagen Remedies LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Infagen Remedies LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Infagen Remedies has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Infagen Remedies LLP, buy the company report.
Recent activity
Infagen Remedies LLP has 3 designated partner changes on record since 2020: 3 appointments. The latest: Harish Kumar Kinger was appointed as Designated Partner on 31 May 2020.
Frequently asked questions
Infagen Remedies is an active limited liability partnership based in Sonipat, Haryana, India. The LLP works in commission trade, within the business services industry. It was incorporated on 31 May 2020 (6+ years old) and is registered under LLPIN AAS-5126.
Infagen Remedies has 3 current designated partners:
- Harish Kumar Kinger - Designated Partner
- Raj Kumar - Designated Partner
- Rajesh Kumar - Designated Partner
The latest financial statements of Infagen Remedies on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 31 March 2023. Year-wise statements from FY 2021 are in the company report.
No. Infagen Remedies has 1 GST registration on record and it is cancelled or inactive.
The LLPIN (Limited Liability Partnership Identification Number) of Infagen Remedies is AAS-5126. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Infagen Remedies has 1 court case on record: 1 filed by the LLP. 1 is pending.
Infagen Remedies was incorporated on 31 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Harish Kumar Kinger was appointed as Designated Partner on 31 May 2020. Raj Kumar was appointed as Designated Partner on 31 May 2020. Rajesh Kumar was appointed as Designated Partner on 31 May 2020.
The registered office of Infagen Remedies is at 477 Sector 15, Sonipat, Haryana, India – 131001.
Infagen Remedies operates in the business services industry, in the commission trade segment.